Growth Metrics

OptimizeRx (OPRX) Change in Account Payables (2016 - 2026)

OptimizeRx's Change in Account Payables history spans 16 years, with the latest figure at -$401000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 33.06% to -$401000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$520000.0, a 622.22% decrease, with the full-year FY2025 number at -$520000.0, down 622.22% from a year prior.
  • Change in Account Payables hit -$401000.0 in Q4 2025 for OptimizeRx, down from $55000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for OPRX hit a ceiling of $1.3 million in Q2 2024 and a floor of -$1.4 million in Q2 2025.
  • Historically, Change in Account Payables has averaged -$49013.6 across 5 years, with a median of -$122985.5 in 2021.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 1074.64% in 2022 and later crashed 4193.47% in 2023.
  • Tracing OPRX's Change in Account Payables over 5 years: stood at -$164837.0 in 2021, then skyrocketed by 433.27% to $549354.0 in 2022, then tumbled by 183.92% to -$461000.0 in 2023, then fell by 29.93% to -$599000.0 in 2024, then skyrocketed by 33.06% to -$401000.0 in 2025.
  • Business Quant data shows Change in Account Payables for OPRX at -$401000.0 in Q4 2025, $55000.0 in Q3 2025, and -$1.4 million in Q2 2025.